DYMISTA Trademark

Trademark Overview

On Wednesday, September 11, 2019, a trademark application was filed for DYMISTA with the United States Patent and Trademark Office. The USPTO has given the DYMISTA trademark a serial number of 88612673. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Meda Pharmaceuticals Inc.. The DYMISTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of allergies
dymista

General Information

Serial Number88612673
Word MarkDYMISTA
Filing DateWednesday, September 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Description of MarkThe mark consists of the word "DYMISTA" in block letters with an upside down check mark shape above the "DY" and a check mark shape below the "DY".
Goods and ServicesPharmaceuticals for the treatment of allergies
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMeda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 5 GRANTED
Thursday, August 11, 2022SOU EXTENSION 5 FILED
Monday, August 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 11, 2022TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 4 GRANTED
Monday, February 14, 2022SOU EXTENSION 4 FILED
Monday, February 14, 2022TEAS EXTENSION RECEIVED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2021SOU EXTENSION 3 GRANTED
Friday, August 13, 2021SOU EXTENSION 3 FILED
Friday, August 13, 2021TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 2 GRANTED
Thursday, February 11, 2021SOU EXTENSION 2 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020SOU EXTENSION 1 GRANTED
Wednesday, August 12, 2020SOU EXTENSION 1 FILED
Wednesday, August 12, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019ASSIGNED TO EXAMINER
Wednesday, September 25, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 14, 2019NEW APPLICATION ENTERED

Related Keywords

dymista allergies treatment pharmaceuticals